Phibro Animal Health Corporation (NASDAQ:PAHC) Announces Quarterly Dividend of $0.12

Key Points

• Phibro Animal Health announced a quarterly dividend of $0.12 per share, payable June 24 to shareholders of record on June 3 (ex‑dividend date June 3), implying a $0.48 annual dividend and a yield of about 0.9%.
• The dividend appears sustainable given a current payout ratio of 23.9%, and analysts forecast $3.28 in EPS next year, which would lower the projected payout ratio to roughly 14.6%.
• Phibro recently beat estimates with quarterly EPS of $0.87 vs. $0.69 expected and $373.9M in revenue, and the stock trades near $56.24 with a market cap of about $2.28B and a 1‑year range of $18.89–$60.08.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) announced a quarterly dividend on Tuesday, May 5th. Investors of record on Wednesday, June 3rd will be given a dividend of 0.12 per share on Wednesday, June 24th. This represents a c) dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Wednesday, June 3rd.

Phibro Animal Health has a payout ratio of 23.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $3.28 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 14.6%.

Phibro Animal Health Stock Performance

Phibro Animal Health stock opened at $56.24 on Wednesday. The firm's 50 day simple moving average is $53.93 and its 200 day simple moving average is $46.34. The company has a current ratio of 3.05, a quick ratio of 1.22 and a debt-to-equity ratio of 2.14. The firm has a market capitalization of $2.28 billion, a PE ratio of 25.00, a price-to-earnings-growth ratio of 0.84 and a beta of 0.61. Phibro Animal Health has a 1-year low of $18.89 and a 1-year high of $60.08.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $0.87 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.18. The business had revenue of $373.91 million for the quarter, compared to analyst estimates of $355.64 million. Phibro Animal Health had a net margin of 6.29% and a return on equity of 38.28%. As a group, analysts expect that Phibro Animal Health will post 3.03 earnings per share for the current fiscal year.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation NASDAQ: PAHC is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.